Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal … – MarketWatch
Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal …MarketWatch"Too many people with rheumatoid arthritis who are treated with methotrexate – commonly used across the disease continuum for 25 years – do not achieve adequate disease control, which can cause disability and impede productivity," said David Ricks …and more »
[monetize id=”1″]
[monetize id=”2″]
Toronto eczema treatment with Chinese Medicine– Dr. Poney …
Can-Fite to Present CF101 Psoriasis Data at Late Breaking Session of the EADV … – PR Newswire (press release)
Can-Fite to Present CF101 Psoriasis Data at Late Breaking Session of the EADV …PR Newswire (press release)Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause Can-Fite's actual results to differ materially from any future results expressed or …Form 6-K Can-Fite BioPharma Ltd. For: Sep 29StreetInsider.comall 3 news articles »
